Two Phase I and Pharmacokinetic Studies of Darinaparsin (Organic Arsenic Compound) in Japanese and Korean Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL)

被引：0
|
作者：
Kim, Won-Seog [1 ]
Ogura, Michinori [2 ,3 ]
Uchida, Toshiki [3 ]
Uike, Naokuni [4 ,5 ]
Abe, Yasunobu [5 ]
Ishizawa, Kenichi [6 ,7 ]
Okitsu, Yoko [6 ]
Tobinai, Kensei [8 ]
Nagahama, Fumiko [9 ]
Sonehara, Yusuke [9 ]
Nagai, Hirokazu [10 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hematol Oncol, Seoul, South Korea
[2] Tokai Cent Hosp, Dept Hematol, Kakamigahara, Japan
[3] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[4] Saga Ken Med Ctr Koseikan, Dept Pallit Care, Saga, Japan
[5] Kyushu Canc Ctr, Natl Hosp Org, Dept Hematol, Fukuoka, Japan
[6] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan
[7] Yamagata Univ, Fac Med, Hematol & Cell Therapy, Yamagata 990, Japan
[8] Natl Canc Ctr, Tokyo, Japan
[9] Solasia Pharma KK, Dev Div, Tokyo, Japan
[10] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EVALUATION OF CARDIOVASCULAR SAFETY OF DARINAPARSIN (ORGANIC ARSENIC COMPOUND) IN JAPANESE AND KOREAN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA
    Kumagai, Y.
    Cai, H.
    Barrett, J.
    Shiraishi, T.
    Hayashi, Y.
    Sonehara, Y.
    Nagahama, F.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E94 - E94
  • [2] Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea
    Ogura, Michinori
    Kim, Won-Seog
    Uchida, Toshiki
    Uike, Naokuni
    Suehiro, Youko
    Ishizawa, Kenichi
    Nagai, Hirokazu
    Nagahama, Fumiko
    Sonehara, Yusuke
    Tobinai, Kensei
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (02) : 218 - 227
  • [3] Responses to romidepsin by line of therapy in patients with relapsed/refractory (R/R) peripheral T-cell lymphoma (PTCL).
    Foss, Francine M.
    Pro, Barbara
    Prince, H. Miles
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Horwitz, Steven M.
    Coiffier, Bertrand
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma
    Negoro, Eiju
    Yamauchi, Takahiro
    Fukuhara, Noriko
    Yamamoto, Kazuhito
    Uchida, Toshiki
    Izutsu, Koji
    Maruyama, Dai
    Terui, Yasuhito
    Nakajima, Hideaki
    Ando, Kiyoshi
    Suehiro, Youko
    Choi, Ilseung
    Kanemura, Nobuhiro
    Nakamura, Nobuhiko
    Yamamoto, Go
    Maeda, Yoshinobu
    Shibayama, Hirohiko
    Nagahama, Fumiko
    Sonehara, Yusuke
    Nagai, Hirokazu
    Tien, Hwei-Fang
    Kwong, Yok-Lam
    Kim, Won-Seog
    Tobinai, Kensei
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2023, 63 (02) : 108 - 120
  • [5] Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)
    Maeda, Yoshinobu
    Tobinai, Kensei
    Nagai, Hirokazu
    Nakane, Takahiko
    Shimoyama, Tatsu
    Nakazato, Tomonori
    Sakai, Rika
    Ishikawa, Takayuki
    Izutsu, Koji
    Ueda, Ryuzo
    [J]. BLOOD, 2016, 128 (22)
  • [6] A Global Phase 2 Study of Valemetostat Tosylate (Valemetostat) in Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL), Including R/R Adult T-Cell Leukemia/Lymphoma (ATL) - Valentine-PTCL01
    Foss, Francine M.
    Porcu, Pierluigi
    Horwitz, Steven M.
    Izutsu, Koji
    Ishitsuka, Kenji
    Kato, Kazunobu
    Jin, Jin
    Du, Yining
    Inoue, Ai
    [J]. BLOOD, 2021, 138
  • [7] COMPLETE RESPONSES (CR/CRU) ON A PHASE 2 STUDY OF ROMIDEPSIN IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (R/R PTCL)
    Pro, B.
    Horwitz, S.
    Foss, F.
    Prince, M.
    Sokol, L.
    Greenwood, M.
    Caballero, D.
    Borchmann, P.
    Nichols, J.
    Balser, J.
    Carroll, S.
    Coiffier, B.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 201 - 202
  • [8] Complete responses (CR/CRu) on a phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL)
    Horwitz, S. M.
    Coiffier, B.
    Foss, F. M.
    Prince, H. M.
    Sokol, L.
    Greenwood, M.
    Caballero, D.
    Borchmann, P.
    Morschhauser, F.
    Wilhelm, M.
    Pinter-Brown, L. C.
    Padmanabhan, S.
    Shustov, A. R.
    Nichols, J.
    Balser, J.
    Carroll, S.
    Pro, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
    Kim, Won-Seog
    Fukuhara, Noriko
    Yoon, Dok-Hyun
    Yamamoto, Kazuhito
    Uchida, Toshiki
    Negoro, Eiju
    Izutsu, Koji
    Terui, Yasuhito
    Nakajima, Hideaki
    Ando, Kiyoshi
    Suehiro, Youko
    Kang, Hye Jin
    Ko, Po-Shen
    Nagahama, Fumiko
    Sonehara, Yusuke
    Nagai, Hirokazu
    Tien, Hwei-Fang
    Kwong, Yok-Lam
    Tobinai, Kensei
    [J]. BLOOD ADVANCES, 2023, 7 (17) : 4903 - 4912
  • [10] Subsequent Hematopoietic Stem Cell Transplantation in Belinostat-Treated Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
    Shustov, Andrei R.
    Al-Ali, Haifa Kathrin
    Wulf, Gerald
    Hsu, Pamela
    Choi, Mi Rim
    Allen, Lee F.
    Visser, Otto J.
    Zachee, Pierre
    Horwitz, Steven M.
    [J]. BLOOD, 2014, 124 (21)
12345